Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sintez is a prominent Russian pharmaceutical company and a key asset within the Binnopharm Group. Established in 1958 and headquartered in Kurgan, it is one of the largest manufacturers of antibiotics and hospital-sector medications in the Russian Federation. The company is unique for its vertically integrated production cycle, synthesizing its own active pharmaceutical ingredients (APIs) for a significant portion of its portfolio. Sintez produces over 300 products across various forms, including ampoules, vials, capsules, and ointments, covering therapeutic areas such as endocrinology, ophthalmology, and cardiology. As a major supplier to the state healthcare system, the company plays a vital role in Russia's import substitution strategy for essential medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sintez.